Finance News

Sprint Corp Brings Monthly Rolling Data For Prepaid Customers; Launches BoostTV Service

Sprint Corp Brings Monthly Rolling Data For Prepaid Customers; Launches BoostTV Service

Sprint Corp (NYSE:S) has lately been putting in endless efforts to improve its network performance and bring enticing promotions and economical service plans to attract more subscribers to its network. The third-largest US wireless network operator on Tuesday introduced its Monthly Rolling Data program for its prepaid customers, which allows […]

Bluebird Bio Inc (BLUE) Has Upside Potential After Altered CAR-T Contract With Celgene Corporation: SunTrust

Bluebird Bio Inc (BLUE) Has Upside Potential After Altered CAR-T Contract With Celgene Corporation: SunTrust

SunTrust predicts upside potential in Bluebird Bio Inc stock on the back of its amended partnership agreement with Celgene Corporation In a research note released on Thursday, SunTrust Robinson Humphrey disclosed that it sees upside potential in the clinical-stage biotech company, Bluebird Bio Inc. (NASDAQ:BLUE), following the amendment of its […]

Actavis Plc: Orexigen Therapeutics, Inc. And Takeda Pharmaceutical File Lawsuit To Block Generic Weight-Loss Pill

Actavis Plc: Orexigen Therapeutics, Inc. And Takeda Pharmaceutical File Lawsuit To Block Generic Weight-Loss Pill

Orexigen Therapeutics, Inc. (NASDAQ:OREX) and its partner Takeda Pharmaceutical Co Ltd (ADR) (OTCMKTS:TKPYY) have filed a lawsuit against Actavis Plc (NYSE:ACT) to block a generic version of a weight-loss pill sold in the market under the name Contrave, according to Reuters. The lawsuit against Actavis Laboratories FL Inc, Andrx Corp, […]

Merck & Co., Inc. Set To Make Waves In Insomnia Drugs Market

Merck & Co., Inc. Set To Make Waves In Insomnia Drugs Market

Merck possibly has a blockbuster drug on its hands, evident from the fact that the company?s insomnia drug prescriptions have been escalating at a rapid rate Merck & Co., Inc. (NYSE:MRK) may have a blockbuster drug on its hands in the form of the new insomnia drug, Belsomra. Belsomra was […]

AbbVie Inc (ABBV) To Tap Into High Revenue Growth From Cancer Drug Imbruvica

AbbVie Inc (ABBV) To Tap Into High Revenue Growth From Cancer Drug Imbruvica

AbbVie?s wholly owned subsidiary, Pharmacyclics, reported positive results for Imbruvica from a late-stage study evaluating the drug in chronic lymphocytic leukemia patients, aged 65 or older AbbVie Inc (NYSE:ABBV) announced that its wholly owned subsidiary, Pharmacyclics LLC, has reported positive results from a late-stage study that evaluated the efficacy of […]